Table 2 The study plan
Screening | Immediate phase (intravenous drip of salvianolate for 30 min) | In-hospital follow-up | |
|---|---|---|---|
Day 1 | Day 1 | Day 7 | |
Inclusion/exclusion criteria | X | ||
Informed consent | X | ||
Randomization | X | ||
Demographic information | X | ||
Medical history | X | ||
Vital signs | X | X | X |
Physical examination | X | X | |
Concomitant medications | X | X | |
CBC | X | X | |
Scr, BUN, UA | X | X | |
K, Na, Cl | X | X | |
ALT, AST, BIL | X | X | |
Fasting glucose/lipids | X | X | |
cTnT/cTnI | X | X | |
Electrocardiography | X | X | |
Echocardiography | X | X | |
Medication | |||
Salvianolate injection | X | X | |
End points | |||
Seattle angina scale | X | X | |
Quality of life scale | X | X | |
Holter electrocardiography | X | X | |
6-min walk test | X | X | |
IMR | X | X | |